Form 8-K - Current report:
SEC Accession No. 0001193125-25-240253
Filing Date
2025-10-15
Accepted
2025-10-15 16:09:10
Documents
10
Period of Report
2025-10-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-20251015.htm   iXBRL 8-K 73374
  Complete submission text file 0001193125-25-240253.txt   213331

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20251015.xsd EX-101.SCH 51192
12 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20251015_htm.xml XML 4711
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 251394921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)